Anna Johnson
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 7
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 4
- Physiology top 5%
- Adenosine and Purinergic Signaling 1
-
- Vascular Tumors and Angiosarcomas 1
- Viral-associated cancers and disorders 1
- Cancer survivorship and care 1
-
- Childhood Cancer Survivors' Quality of Life 1
In The Last Decade
Anna Johnson
10 papers receiving 777 citations
Peers
Comparison fields: 5 of 48
- Genetics 605
- Pathology and Forensic Medicine 554
- Immunology 378
- Physiology 65
- Oncology 154
Countries citing papers authored by Anna Johnson
This map shows the geographic impact of Anna Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Johnson more than expected).
Fields of papers citing papers by Anna Johnson
This network shows the impact of papers produced by Anna Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Johnson. The network helps show where Anna Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 5 | |
| 2 | prognosis in chronic lymphocytic leukemia CD38 expression is a poor predictor for VH gene mutational status and | 2013 | 1 |
| 3 | 2003 | 65 | |
| 4 | 2003 | 43 | |
| 5 | 2003 | 232 | |
| 6 | 2003 | 1 | |
| 7 | 2002 | 72 | |
| 8 | 2002 | 82 | |
| 9 | 2002 | 234 | |
| 10 | 1999 | 51 |
About Anna Johnson
Anna Johnson is a scholar working on Genetics, Pathology and Forensic Medicine, Physiology, Immunology and Oncology, having authored 10 papers that have together received 786 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Vascular Tumors and Angiosarcomas (1 paper), Adenosine and Purinergic Signaling (1 paper), Viral-associated cancers and disorders (1 paper), Cancer survivorship and care (1 paper) and Childhood Cancer Survivors' Quality of Life (1 paper). The work is most often cited by research in Genetics (605 citations), Pathology and Forensic Medicine (554 citations), Immunology (378 citations), Physiology (65 citations) and Oncology (154 citations). Anna Johnson has collaborated with scholars based in Sweden, Finland and Norway. Frequent co-authors include Christer Sundström, Ulf Thunberg, Richard Rosenquist, Göran Roos, Gunilla Enblad, Gerard Tobin, Ola Söderberg, Magnus Hultdin, Inger Eriksson and Ingrid Thörn. Their work appears in journals such as Blood, European Journal Of Haematology, The Lancet, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.